A detailed history of Federated Hermes, Inc. transactions in Biote Corp. stock. As of the latest transaction made, Federated Hermes, Inc. holds 1,143 shares of BTMD stock, worth $6,972. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,143
Previous 121 844.63%
Holding current value
$6,972
Previous $0 Infinity%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$5.33 - $8.36 $5,447 - $8,543
1,022 Added 844.63%
1,143 $6,000
Q2 2024

Aug 08, 2024

BUY
$5.44 - $7.47 $658 - $903
121 New
121 $0
Q2 2023

Aug 14, 2023

BUY
$5.27 - $6.9 $147 - $193
28 New
28 $0

Others Institutions Holding BTMD

About biote Corp.


  • Ticker BTMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Care Facilities
  • Shares Outstandng 7,574,270
  • Market Cap $46.2M
  • Description
  • biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biot...
More about BTMD
Track This Portfolio

Track Federated Hermes, Inc. Portfolio

Follow Federated Hermes, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.